NTIS Publication Number

Study
Number

Description

PB93506087

ACTG 002

AIDS Clinical Trials Group 002: Analysis Data Set (for Microcomputers). - Data file.

PB94501871

ACTG 019

Safety and Efficacy of Zidovudine for Asymptomatic HIV Infected Individuals (for Microcomputers). - Data file.

PB95500229

ACTG 021

Controlled Comparative Trial of Trimethoprim-Sulfamethazole (T-SMZ) Versus Aerosolized Pentamidine (AP) for Secondary Prophylaxis of PCP in AIDS Patients Receiving Azidothymidine (AZT) (July 1988-November 1990) (for Microcomputers). - Data file.

PB97501258

ACTG 051

AIDS Clinical Trials Group Study (ACTG 051): A Double-Blind Placebo-Controlled Trial to Evaluate Intravenous Gamma Globulin in Children with Symptomatic HIV Infection Receiving Zidovudine (for Microcomputers). - Data file.

Not Available ACTG 076 A Phase III Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety and Tolerance of Zidovudine for the Prevention of Maternal-Fetal HIV Transmission.

PB96502141

ACTG 081

ACTG 081 Publication Data Set (for Microcomputers). - Data file.

Not Available ACTG 116A

Zidovudine Compared With Didanosine in Patients With Advanced HIV
Type 1 Infection and Little or No Previous Experience With Zidovudine"

PB94504099

ACTG 116B/117

Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddl)(Bmy-40900) and Zidovudine Therapy of Patients with HIV Infection Who Have Been on Long Term Zidovudine Treatment (ACTG116B/117) (for Microcomputers). - Data file.

PB99500571

ACTG 128

ACTG 128: A Randomized Blinded Trial to Evaluate the Safety and Tolerance of High Versus Low Dose Zidovudine Administered to Children with Human Immunodeficiency Virus (on Diskette). - Data file.

PB93120574

ACTG 129

Studies of the Ocular Complication of AIDS (SOCA) CMV Retinitis Trial: Foscarnet Ganciclovir Component AIDS Clinical Trial Group (ACTG) Protocol 129. Handbook (Version 2.0). - Clinical trial handbook.

PB2002107313

ACTG 129

Database Documentation for Mortality in Patients with Acquired Immunodeficiency Treated with Either Foscarnet or Ganciclovir for Cytomegalovirus Retinitis: The Foscarnet-Ganciclovir CMV Retinitits Trail (FGCRT). - Final rept.

PB96109731

ACTG 129

Studies of the Ocular Complications of AIDS (SOCA) Foscarnet Ganciclovir CMV Retinitis Trial (FGCRT) Morbidity and Toxicity. AIDS Clinical Trials Group (ACTG) Protocol 129. - Clinical trial handbook.

PB96109756

ACTG 129

Studies of Ocular Complications of AIDS (SOCA). Foscarnet- Ganciclovir Cytomegalovirus Retinitis Trial (FGCRT). AIDS Clinical Trial Group (ACTG) Protocol 129. Antiviral Effects of Foscarnet and Ganciclovir Therapy on HIV p24 Antigen in Patients with AIDS and Cytomegalovirus. - Clinical trial handbook.

PB2004500001

ACTG 142

Phase 3 Randomized Trial of Low Dose Versus Standard Dose m-BACOD Chemotherapy with rGM-CSF for Treatment of AIDS-Associated Non-Hodgkins Lymphona (ACTG 142). - Data files.

PB2004100661

ACTG 142

Phase 3 Randomized Trial of Low Dose Versus Standard Dose m-BACOD Chemotherapy with rGM-CSF for Treatment of AIDS-Associated Non-Hodgkins Lymphona (ACTG 142) Documentation. - Final rept.

PB96502695

ACTG 155

Analysis Datasets for ACTG 155 (for Microcomputers). - Data file.

PB98172539

ACTG 175

ACTG 175: Randomized, Double-Blind Phase 2/3 Trial of Monotherapy vs. Combination Therapy with Nucleoside Analogues in HIV-Infected Persons with CD4 Cells >/=200 and </=500/cmm. Final Protocol and List of Changes.

PB99500159

ACTG 175

ACTG 175: A Randomized, Double-Blind, Placebo-Controlled Trial (on Diskette).

PB99500167

ACTG 175

ACTG 175: A Virology Substudy (on Diskette). - Data file.

PB2003500100

ACTG 193A

Studies of the Ocular Complications of AIDS (SOCA) in Collaboration with the AIDS Clinical Trials Group (ACTG) Protocol 350 Ganciclovir Cidofovir CMV Retinitis Trial (GCCRT) Data Collection Forms (as of 24 September 1999).

PB2006500029 ACTG 193A

"A Randomized, Controlled, Double-Blind Study Comparing the Survival Benefit of Four Different Reverse Transcriptase Inhibitor Therapies (Three-Drug, Two-Drug, and Alternating Drug) for the Treatment of Advanced AIDS"

PB2006500029 ACTG 196 ACTG 196: Aids Clinical Trials Group (on CD-ROM). The efficacy and safety of clarithromycin, 500 mg BID, rifabutin, 300-450 mg QD, and the combination for prevention of Mycobacterium avium complex (MAC) disease were compared in a randomized, double-blinded, placebo-controlled trial in patients with AIDS.
PB2005500119 ACTG 200 ACTG 200: A Phase III, Randomized Trial of Topical Vaginal Fluorouracil Maintenance Therapy vs. Observation After Standard Treatment for High Grade Cervical Dysplasia in HIV-Infected Women. 

PB2004500003

ACTG 204

Randomized, Double-Blind Trial of Valacyclovir Prophylaxis for Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Infection (ACTG 204) (on diskette). - Data file.

PB2004100662

ACTG 204

Randomized, Double-Blind Trial of Valacyclovir Prophylaxis for Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Infection (ACTG 204) Documentation.

PB2004100662 ACTG 204

"A Randomized, Double-Blind Trial of Valaciclovir Prophylaxis for Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Infection"

PB96109723

ACTG 228

Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Retreatment Trial (CRRT). AIDS Clinical Trial Group (ACTG) protocol 228. - Data collection forms.

PB96109749

ACTG 228

Studies of the Ocular Complications of AIDS (SOCA). CMV Retinitis Retreatment Trial (CRRT) Handbook (Version 1.0). AIDS Clinical Trials Group (ACTG) 228. - Clinical trial handbook.

PB96109715

ACTG 228

Studies of Ocular Complications of AIDS (SOCA). CMV Retinitis Retreatment Trial CRRT, ACTG 228. Protocol, Version 2.2. December 1, 1992. - Clinical trials.

PB99501629 ACTG 240

"A Randomized, Double-Blind Trial of Valaciclovir Prophylaxis for Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Infection"

PB99502114

ACTG 251

ACTG 251: Esophageal Stratum (on Diskette). - Data file.

PB99501645

ACTG 251

ACTG 251: Oral Aphthous Ulcers (on Diskette). - Data file.

PB97170310

ACTG 281

Studies of Ocular Complications of AIDS. HPMPC Peripheral CMV Retinitis Trial, Protocol, Version 1.4.

PB97170328

ACTG 281

SOCA HPMPC Peripheral CMV Retinitis Trial (HPCRT). Manual (Version 1.1).

PB97170195

ACTG 281

Studies of the Ocular Complications of AIDS. HPMPC Peripheral CMV Retinitis Trial (HPCRT). Forms Book.

PB2005500120 ACTG 293 ACTG 293: A Randomized Phase III Trial of Oral Isotretinoin vs. Observation for Low Grade Squamous Intraepithelial Lesions in HIV Infected Women.

PB97170336

ACTG 294

Studies of Ocular Complications of AIDS (SOCA). A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT). Version 2.

PB97170351

ACTG 294

Studies of the Ocular Complications of AIDS (SOCA). Monoclonal Antibody CMV Retinitis Trial (MACRT) Forms and Charts Notebook.

PB97170344

ACTG 294

Studies of the Ocular Complications of AIDS (SOCA). Monoclonal Antibody CMV Retinitis Trial (MACRT) Manual (Version 1.0).

PB2002108495

ACTG 294

Studies of Ocular Complications of AIDS (SOCA). The Monoclonal Cytomegalovirus Retinitis Trial (MARCT) Database Documentation for MSL-109 Adjuvant Therapy for Cytomegalovirus Retinitis in Patients with Acquired Immunodeficiency Syndrome (AIDS) Archives of Ophthalmology 115:1528-1536, 1997.

Not Available ACTG 320 A Randomized, Double-Blind, Phase III Study of Indinavir Sulfate (IDV) with Open-Label ZDV or Stavudine (d4T) and Lamivudine (3TC) in Subjects with HIV Infection with CD4 Cell Counts <= 200 Cells/mm3 and >= 3 Months of Prior Zidovudine (ZDV).

PB2004500016

ACTG 338

Nucleoside Analogs Plus Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: A Randomized Controlled Trial (ACTG 338) (raw data on CD-ROM).

PB2004500016 ACTG 338 Nucleoside Analogs Plus Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: A Randomized Controlled Trial (ACTG 338) (raw data on CD-ROM).  

PB2002107314

ACTG 350

Studies of the Ocular Complications of AIDS (SOCA) in Collaboration with the AIDS Clinical Trials Group (ACTG) Protocol 350 Ganciclovir Cidofovir CMV Retinitis Trial (GCCRT) Protocol, Version 6.1 (dated 06 Auguest 1999).

PB2002107308

ACTG 350

Studies of the Ocular Complications of AIDS (SOCA) in Collaboration with the Database Documentation for Ganciclovir Implant Pus Oral Ganciclovir Versus Parenteral Cidofovir for the Treament of Cytomegalovirus Tetinitis in Patients with Acquired Immunodeficiency Syndrome: The Ganciclovir Cidofovir CMV Retinitis Trial (GCCRT).

PB2002107315

ACTG 350

Studies of the Ocular Complications of AIDS (SOCA) in Collaboration with the AIDS Clinical Trials Group (ACTG) Protocol 350 Ganciclovir Cidofovir CMV Retinitis Trial (GCCRT) Data Collection Forms (as of 24 September 1999).

PB2002107310

ACTG 350

Studies of the Ocular Complications of AIDS (SOCA) in Collaboration with the AIDS Clinical Trials Group (ACTG) Protocol 350 Ganciclovir Cidofovir CMV Retinitis Trial (GCCRT) Handbook (Version 3 dated 2 September 1999).

PB2005500116 ACTG 384 Study of Protease Inhibitor and/or Non-nucleoside Reverse Transcriptase Inhibitor with Dual Nucleosides in Initial Therapy of HIV Infection (on CD-ROM).
PB2005500118 ACTG 388 A Randomized Trial of 2 Different 4-Drug Antiretroviral Regimens Versus a 3-Drug Regimen in Advanced Human Immunodeficiency Virus (on CD-ROM).

PB96502158

ACTG 931

ACTG 981 Publication Data Set (for Microcomputers). - Data file.

PB2005500135 ACTG 5071

5071: A Prospective, Multicenter, PhaseII/III, Open-Label, Controlled Randomized Trial Evaluating Safety, Efficacy and Tolerability of IFN-alfa-2a + Ribavirin Versus PEG-IFN-alfa-2a + Ribavirin for Chronic HCV Infection in Individuals Coinfected with HIV-1.